PREGNALIFE CAPSULES

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

ascorbic acid, Quantity: 50 mg; calcium pantothenate, Quantity: 5.5 mg (Equivalent: pantothenic acid, Qty 5 mg); calcium hydrogen phosphate dihydrate, Quantity: 214.59 mg (Equivalent: calcium, Qty 50 mg); potassium iodide, Quantity: 0.1 mg (Equivalent: iodine, Qty 76.4 microgram; Equivalent: potassium, Qty 23.6 microgram); cyanocobalamin, Quantity: 1.5 microgram; thiamine hydrochloride, Quantity: 1 mg; nicotinamide, Quantity: 10 mg; natural fish oil, Quantity: 150 mg; ferrous fumarate, Quantity: 15.2 mg (Equivalent: iron, Qty 5 mg); Fucus vesiculosus, Quantity: 60 mg (Equivalent: Fucus vesiculosus, Qty 300 mg; Equivalent: iodine, Qty 0.1 mg); Zingiber officinale, Quantity: 50 mg (Equivalent: Zingiber officinale, Qty 500 mg); magnesium oxide, Quantity: 50 mg (Equivalent: magnesium, Qty 30.15 mg); betacarotene, Quantity: 1.5 mg; folic acid, Quantity: 250 microgram; zinc gluconate, Quantity: 69.69 mg (Equivalent: zinc, Qty 10 mg); d-alpha-tocopheryl acid succinate, Quantity: 12.4 mg (Equivalent: d-alpha-tocopheryl acid succinate, Qty 15 IU); riboflavin, Quantity: 1 mg; pyridoxine hydrochloride, Quantity: 1 mg (Equivalent: pyridoxine, Qty 0.823 mg)

Disponible depuis:

Vitex Pharmaceuticals Pty Ltd

DCI (Dénomination commune internationale):

Ascorbic acid,Betacarotene,calcium hydrogen phosphate dihydrate,Calcium pantothenate,Cyanocobalamin,d-alpha-Tocopheryl acid succ

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: amaranth; Gelatin; titanium dioxide; colloidal anhydrous silica; stearic acid; sodium lauryl sulfate; brilliant blue FCF; purified water; macrogol 6000

Mode d'administration:

Oral

indications thérapeutiques:

Maintain/support healthy pregnancy

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2017-10-18